Trial
NCT05517837
A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants
Early Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Healthy Participants
Intervention
BMS-986421
Why stopped
Adverse change in the risk/benefit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13